Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 67 Records) |
| Query Trace: Colorectal Neoplasms and FBXW7[original query] |
|---|
| Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial. European journal of cancer (Oxford, England : 1990) 2020 Aug 137 250-259. Stahler Arndt, Stintzing Sebastian, von Einem Jobst C, Westphalen Christoph B, Heinrich Kathrin, Krämer Nicole, Michl Marlies, Modest Dominik P, von Weikersthal Ludwig Fischer, Decker Thomas, Kiani Alexander, Heintges Tobias, Kahl Christoph, Kullmann Frank, Scheithauer Werner, Moehler Markus, Kaiser Florian, Kirchner Thomas, Jung Andreas, Heinemann Volk |
| Tissue gene mutation profiles in patients with colorectal cancer and their clinical implications. Biomedical reports 2020 5 13 (1): 43-48. Ye Jun, Lin Mei, Zhang Chuanmeng, Zhu Xiaowei, Li Sumeng, Liu Hui, Yin Jianfeng, Yu Hong, Zhu Kuich |
| Genomic variation as a marker of response to neoadjuvant therapy in locally advanced rectal cancer. Molecular & cellular oncology 2020 7 (3): 1716618. Douglas Jason K, Callahan Rose E, Hothem Zachary A, Cousineau Craig S, Kawak Samer, Thibodeau Bryan J, Bergeron Shelli, Li Wei, Peeples Claire E, Wasvary Harry |
| Characterization of genomic alterations in Chinese colorectal cancer patients. Japanese journal of clinical oncology 2020 Oct . Huang Wei, Li Hui, Shi Xiaoliang, Lin Minglin, Liao Cun, Zhang Shuirong, Shi Weiwei, Zhang Lin, Zhang Xiaolong, Gan Jialia |
| Germline mutations in a DNA repair pathway are associated with familial colorectal cancer. JCI insight 2021 9 6 (18): . Xu Pingping, Sun Danfeng, Gao Yaqi, Jiang Yi, Zhong Ming, Zhao Gang, Chen Jinxian, Wang Zheng, Liu Qiang, Hong Jie, Chen Haoyan, Chen Ying-Xuan, Fang Jing-Yu |
| Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis. BMC cancer 2021 7 21 (1): 770. Shang Wei, Yan Chuanwang, Liu Ran, Chen Lili, Cheng Dongdong, Hao Liang, Yuan Wenguang, Chen Jingbo, Yang H |
| Immuno-genomic classification of colorectal cancer organoids reveals cancer cells with intrinsic immunogenic properties associated with patient survival. Journal of experimental & clinical cancer research : CR 2021 7 40 (1): 230. Cho Eun Jeong, Kim Minsuh, Jo Daum, Kim Jihye, Oh Ji-Hye, Chung Hee Chul, Lee Sun-Hye, Kim Deokhoon, Chun Sung-Min, Kim Jihun, Lee Hyeonjin, Kim Tae Won, Yu Chang Sik, Sung Chang Ohk, Jang Se J |
| Enhancing the landscape of colorectal cancer using targeted deep sequencing. Scientific reports 2021 Apr 11 (1): 8154. Lee Chul Seung, Song In Hye, Lee Ahwon, Kang Jun, Lee Yoon Suk, Lee In Kyu, Song Young Soo, Lee Sung H |
| Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients. Aging 2021 Mar 13 (6): 9043-9055. Peng Linglong, Li Yang, Gu Haitao, Xiang Ling, Xiong Yongfu, Wang Rong, Zhou He, Wang Jiji |
| Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy. Anticancer research 2021 Feb 41 (2): 829-834. Nakamura Masaki, Kageyama Shun-Ichiro, Seki Masahide, Suzuki Ayako, Okumura Masayuki, Hojo Hidehiro, Motegi Atsushi, Akimoto Tets |
| Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features. Nature communications 2021 01 12 (1): 574. Mendelaar Pauline A J, Smid Marcel, van Riet Job, Angus Lindsay, Labots Mariette, Steeghs Neeltje, Hendriks Mathijs P, Cirkel Geert A, van Rooijen Johan M, Ten Tije Albert J, Lolkema Martijn P, Cuppen Edwin, Sleijfer Stefan, Martens John W M, Wilting Saskia |
| The Genomic Environment of BRAF Mutated and BRAF/PIK3CA Double Mutated Colorectal Cancers. Journal of clinical medicine 2022 9 11 (17): . Voutsadakis Ioannis |
| A RAS-Independent Biomarker Panel to Reliably Predict Response to MEK Inhibition in Colorectal Cancer. Cancers 2022 7 14 (13): . Pfohl Ulrike, Loskutov Jürgen, Bashir Sanum, Kühn Ralf, Herter Patrick, Templin Markus, Mamlouk Soulafa, Belanov Sergei, Linnebacher Michael, Bürtin Florian, Vetter Marcus, Reinhard Christoph, Wedeken Lena, Regenbrecht Christian R |
| Association between germline variants and somatic mutations in colorectal cancer. Scientific reports 2022 Jun 12 (1): 10207. Barfield Richard, Qu Conghui, Steinfelder Robert S, Zeng Chenjie, Harrison Tabitha A, Brezina Stefanie, Buchanan Daniel D, Campbell Peter T, Casey Graham, Gallinger Steven, Giannakis Marios, Gruber Stephen B, Gsur Andrea, Hsu Li, Huyghe Jeroen R, Moreno Victor, Newcomb Polly A, Ogino Shuji, Phipps Amanda I, Slattery Martha L, Thibodeau Stephen N, Trinh Quang M, Toland Amanda E, Hudson Thomas J, Sun Wei, Zaidi Syed H, Peters Ulri |
| FBXW7 and Its Downstream NOTCH Pathway Could be Potential Indicators of Organ-Free Metastasis in Colorectal Cancer. Frontiers in oncology 2021 11 783564. Li Dongzheng, Jiang Shiye, Zhou Xin, Si Chengshuai, Shao Peng, Jiang Qian, Zhu Liuqing, Shen Lu, Meng Qi, Yin Jiani C, Shao Yang, Sun Yueming, Yang L |
| A stop-gain mutation in GXYLT1 promotes metastasis of colorectal cancer via the MAPK pathway. Cell death & disease 2022 4 13 (4): 395. Peng Lin, Zhao Min, Liu Tianqi, Chen Jiangbo, Gao Pin, Chen Lei, Xing Pu, Wang Zaozao, Di Jiabo, Xu Qiang, Qu Hong, Jiang Beihai, Su Xiangqi |
| FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies. European journal of cancer (Oxford, England : 1990) 2022 4 167 23-31. Antoniotti Carlotta, Germani Marco M, Rossini Daniele, Lonardi Sara, Pietrantonio Filippo, Santini Daniele, Marmorino Federica, Allegrini Giacomo, Daniel Francesca, Raimondi Alessandra, Borelli Beatrice, Zaniboni Alberto, Conca Veronica, Abraham Jim, Spetzler David, Maiello Evaristo, Boccaccino Alessandra, Passardi Alessandro, Giordano Mirella, Tamburini Emiliano, Korn Michael W, Masi Gianluca, Cremolini Chia |
| ERBB2 Mutations as Potential Predictors for Recurrence in Colorectal Serrated Polyps by Targeted Next-Generation Sequencing. Frontiers in oncology 2022 4 12 769709. Wang Qi-Wen, Wang Xin-Yuan, Zhang Qing-Wei, Chen Jin-Nan, Zhou Yu-Jie, Tang Zhao-Rong, Wang Rui-Lan, Chen Haoyan, Chen Huimin, Li Xiao- |
| A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR). ESMO open 2022 12 7 (6): 100592. Okamoto W, Sakai K, Makiyama A, Yamamoto Y, Shitara K, Denda T, Izawa N, Nakano Y, Nishina T, Esaki T, Hara H, Miura Y, Boku N, Yamazaki K, Hironaka S, Misumi T, Hyodo I, Muro K, Nishio |
| Investigating genomic, proteomic, and post-transcriptional regulation profiles in colorectal cancer: a comparative study between primary tumors and associated metastases. Cancer cell international 2023 9 23 (1): 192. Hersh Ham-Karim, Ola Negm, Narmeen Ahmad, Mohammad Ily |
| Pathobionts in the tumour microbiota predict survival following resection for colorectal cancer. Microbiome 2023 5 11 (1): 100. James L Alexander, Joram M Posma, Alasdair Scott, Liam Poynter, Sam E Mason, M Luisa Doria, Lili Herendi, Lauren Roberts, Julie A K McDonald, Simon Cameron, David J Hughes, Vaclav Liska, Simona Susova, Pavel Soucek, Verena Horneffer-van der Sluis, Maria Gomez-Romero, Matthew R Lewis, Lesley Hoyles, Andrew Woolston, David Cunningham, Ara Darzi, Marco Gerlinger, Robert Goldin, Zoltan Takats, Julian R Marchesi, Julian Teare, James Kinro |
| Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910. Cancer science 2023 5 . Dai Shida, Aya Kuchiba, Tatsuhiro Shibata, Tetsuya Hamaguchi, Satoshi Yamasaki, Masaaki Ito, Takaya Kobatake, Toru Tonooka, Tadahiko Masaki, Manabu Shiozawa, Yasumasa Takii, Hiroyuki Uetake, Shu Okamura, Hitoshi Ojima, Shinsuke Kazama, Hiroshi Takeyama, Keisuke Kanato, Yasuhiro Shimada, Yoshinori Murakami, Yukihide Kanemit |
| Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer center network. Molecular oncology 2023 4 . Núria Mulet Margalef, Carmen Castillo, Miguel Mosteiro, Xavier Pérez, Susana Aguilar, Fiorella Ruíz-Pace, Marta Gil, Carmen Cuadra, José Carlos Ruffinelli, Mercedes Martínez, Ferran Losa, Gema Soler, Àlex Teulé, Roser Castany, Rosa Gallego, Andrea Ruíz, Elena Garralda, Elena Élez, Ana Vivancos, Josep Tabernero, Ramon Salazar, Rodrigo Dienstmann, Cristina Sant |
| Comprehensive characterization of FBXW7 mutational and clinicopathological profiles in human colorectal cancers. Frontiers in oncology 2023 4 13 1154432. Liu Yiping, Chen Hanlin, Bao Hua, Zhang Jinfeng, Wu Runda, Zhu Lingj |
| Onco-microbial community profiling identifies clinico-molecular and prognostic subtypes of colorectal cancer. Gastroenterology 2023 3 . Mouradov Dmitri, Greenfield Paul, Li Shan, In Eun-Jung, Storey Claire, Sakthianandeswaren Anuratha, Georgeson Peter, Buchanan Daniel D, Ward Robyn L, Hawkins Nicholas J, Skinner Iain, Jones Ian T, Gibbs Peter, Ma Chenkai, Liew Yi Jin, Fung Kim Y C, Sieber Oliver |
| Mutation patterns in colorectal cancer and their relationship with prognosis. Heliyon 2024 9 10 (17): e36550. Zhaoran Su, Maria El Hage, Michael Linnebach |
| Targeted panel sequencing of pharmacogenes and oncodrivers in colorectal cancer patients reveals genes with prognostic significance. Human genomics 2024 7 18 (1): 83. Lucie Heczko, Václav Liška, Ond?ej Vy?ítal, Ond?ej Fiala, Simona Š?sová, Viktor Hlavá?, Pavel Sou? |
| Targeted variant prevalence of FBXW7 gene mutation in colorectal carcinoma propagation. The first systematic review and meta-analysis. Heliyon 2024 6 10 (11): e31471. Hafeez Abiola Afolabi, Salzihan Md Salleh, Zaidi Zakaria, Ch'ng Ewe Seng, Norasikin Mohd Nafi, Ahmad Aizat Bin AbdulAziz, Yusuf Wada, Ahmad Adebayo Irekeola, Sameer Badri Al-Ml-Hanna, Ali Mus |
| Correlation between NGS panel-based mutation results and clinical information in colorectal cancer patients. Heliyon 2024 4 10 (7): e29299. Bo Cheng, Lin Xu, Yunzhi Zhang, Huimin Yang, Shan Liu, Shanshan Ding, Huan Zhao, Yi Sui, Chan Wang, Lanju Quan, Jinhong Liu, Ye Liu, Hongming Wang, Zhaoqing Zheng, Xizhao Wu, Jing Guo, Zhaohong Wen, Ruya Zhang, Fei Wang, Hongmei Liu, Suozhu S |
| FBXW7 polymorphism asserts susceptibility to colorectal cancer. Gene 2024 1 901 148181. Laraib Uroog, Bushra Zeya, Khalid Imtiyaz, Rauf Ahmad Wani, M Moshahid Alam Riz |
- Page last reviewed:Feb 1, 2024
- Content source: